Operating Income: The income after operating expenses.
Agios Pharmaceuticals, Inc. (AGIO) had Operating Income of $-106.63M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$8.73M |
|
$-89.29M |
|
$1.08M |
|
$7.64M |
|
$115.36M |
|
|
Operating Income |
$-106.63M |
$17.34M |
|
$-89.29M |
|
$-89.29M |
|
$-89.29M |
|
$-89.29M |
|
$-89.29M |
|
$-89.29M |
|
$-106.63M |
|
$-106.70M |
|
57.46M |
|
57.46M |
|
$-1.55 |
|
$-1.55 |
|
| Balance Sheet Financials | |
$968.62M |
|
$11.07M |
|
$586.90M |
|
$1.56B |
|
$52.37M |
|
-- |
|
$36.62M |
|
$88.99M |
|
$1.47B |
|
$1.47B |
|
$1.47B |
|
57.89M |
|
| Cash Flow Statement Financials | |
$-111.49M |
|
$112.59M |
|
$1.62M |
|
$76.25M |
|
$78.96M |
|
$2.72M |
|
$11.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.57% |
|
-1221.97% |
|
-1221.97% |
|
-- |
|
-1023.25% |
|
-1023.25% |
|
$-112.25M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.04 |
|
2.61 |
|
34.49 |
|
-6.09% |
|
-6.09% |
|
-5.74% |
|
-6.09% |
|
$25.33 |
|
$-1.95 |
|
$-1.94 |
|